Side effect analysis suggests Gilead's hep C wonder Sovaldi is safer than rivals, too

Save

Gilead Sciences' breakthrough drug Sovaldi isn't just the newest hepatitis C drug to hit the market, or the fastest-selling. It's also the safest, according to an early analysis of adverse event reports.